0001628280-18-000511.txt : 20180222 0001628280-18-000511.hdr.sgml : 20180222 20180119165224 ACCESSION NUMBER: 0001628280-18-000511 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20180119 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Menlo Therapeutics, Inc. CENTRAL INDEX KEY: 0001566044 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 453757789 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 200 CARDINAL WAY, 2ND FLOOR CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-486-1416 MAIL ADDRESS: STREET 1: 200 CARDINAL WAY, 2ND FLOOR CITY: REDWOOD CITY STATE: CA ZIP: 94063 FORMER COMPANY: FORMER CONFORMED NAME: Menlo Therapeutics, Inc. DATE OF NAME CHANGE: 20170728 FORMER COMPANY: FORMER CONFORMED NAME: Tigercat Pharma, Inc. DATE OF NAME CHANGE: 20130104 CORRESP 1 filename1.htm Document

JEFFERIES LLC
520 Madison Avenue
New York, New York 10022

PIPER JAFFRAY & CO
50 California Street, Suite 3100
San Francisco, California 94111

GUGGENHEIM SECURITIES, LLC
330 Madison Avenue
New York, New York 10017

VIA EDGAR
January 19, 2018

U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, N.E. Washington, D.C. 20549-3628

Attention:
Christine Torney
 
Jim Rosenberg
 
Chris Edwards
 
Erin Jaskot
 
 
 
 
Re:
Menlo Therapeutics Inc. Registration Statement on Form S-1
 
 
File No. 333-222324
 
 
Acceleration Request

Ladies and Gentlemen:

As representatives of the several underwriters of the proposed public offering of 5,666,667 shares of common stock of Menlo Therapeutics Inc. (the “Company”), we hereby join the Company’s request to accelerate the date of the above-referenced Registration Statement, as then amended, effective as of 4:30 p.m. (New York time) on January 22, 2018, or as soon thereafter as is practicable.

Pursuant to Rule 460 under the Securities Act of 1933, as amended, we wish to advise you that we have distributed approximately 705 copies of the Company’s preliminary prospectus, dated January 12, 2018, through the date hereof, to underwriters, dealers, institutions and others. The undersigned have been informed by the participating underwriters that they have complied and will continue to comply with Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

(Signature Page Follows)





Very truly yours,
 
 
JEFFERIES LLC
PIPER JAFFRAY & CO
GUGGENHEIM SECURITIES, LLC
As representatives of the several underwriters
 
 
By:
JEFFERIES LLC
 
 
 
 
By:
/s/ Michael Brinkman
 
Name: Michael Brinkman
 
Title: Managing Director
 
 
By:
PIPER JAFFRAY & CO
 
 
 
 
By:
/s/ Christie L. Christina
 
Name: Christie L. Christina
 
Title: Managing Director
 
 
By:
GUGGENHEIM SECURITIES, LLC
 
 
 
 
By:
/s/ Shiv Taylor
 
Name: Shiv Taylor
 
Title: Senior Managing Director

[Signature Page – Acceleration Request]